BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/26/2019 3:26:03 AM | Browse: 764 | Download: 986
Publication Name World Journal of Clinical Cases
Manuscript ID 42867
Country/Territory Japan
Received
2018-11-23 00:35
Peer-Review Started
2018-11-23 09:59
To Make the First Decision
2019-01-14 00:53
Return for Revision
2019-01-15 04:24
Revised
2019-01-27 10:25
Second Decision
2019-02-26 10:55
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2019-02-26 18:22
Articles in Press
2019-02-26 18:22
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2019-03-24 06:25
Publish the Manuscript Online
2019-03-26 03:26
ISSN 2307-8960 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Case Report
Article Title Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by concurrent chemoradiotherapy for unresectable sinonasal undifferentiated carcinoma: Two cases of report
Manuscript Source Unsolicited Manuscript
All Author List Sho Watanabe, Yoshitaka Honma, Naoya Murakami, Hiroshi Igaki, Taisuke Mori, Hidekazu Hirano, Natsuko Okita, Hirokazu Shoji, Satoru Iwasa, Atsuo Takashima, Ken Kato, Kenya Kobayashi, Fumihiko Matsumoto, Seiichi Yoshimoto, Jun Itami and Narikazu Boku
ORCID
Author(s) ORCID Number
Sho Watanabe http://orcid.org/0000-0002-7489-5121
Yoshitaka Honma http://orcid.org/0000-0002-4209-4493
Naoya Murakami http://orcid.org/0000-0003-0660-9987
Hiroshi Igaki http://orcid.org/0000-0001-7817-624X
Taisuke Mori http://orcid.org/0000-0003-1838-7883
Hidekazu Hirano http://orcid.org/0000-0003-1343-1419
Natsuko Okita http://orcid.org/0000-0002-3990-5048
Hirokazu Shoji http://orcid.org/0000-0002-8922-5227
Satoru Iwasa http://orcid.org/0000-0003-3863-9582
Atsuo Takashima http://orcid.org/0000-0002-8456-1248
Ken Kato http://orcid.org/0000-0002-1733-5072
Kenya Kobayashi http://orcid.org/0000-0002-5823-3718
Fumihiko Matsumoto http://orcid.org/0000-0002-0802-8011
Seiichi Yoshimoto http://orcid.org/0000-0001-9270-095X
Jun Itami http://orcid.org/0000-0003-1579-7406
Narikazu Boku http://orcid.org/0000-0002-1438-707X
Funding Agency and Grant Number
Corresponding Author Yoshitaka Honma, MD, Chief Doctor, Department of Head and Neck Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo 1040045, Japan. yohonma@ncc.go.jp
Key Words Sinonasal undifferentiated carcinoma; Chemotherapy with docetaxel, cisplatin and fluorouracil chemotherapy; Docetaxel; Cisplatin; Fluorouracil; Intensity-modulated radiotherapy; Chemoradiotherapy; Case report
Core Tip Sinonasal undifferentiated carcinoma easily invades adjacent organs and is often diagnosed in unresectable disease. Though multimodality treatment has been developed, there is no standard of care for locally advanced Sinonasal undifferentiated carcinoma (LA-SNUC) and the patient outcome remains dismal. We report two cases of unresectable LA-SNUC in which induction chemotherapy with docetaxel, cisplatin and fluorouracil (TPF) followed by cisplatin-based concurrent chemoradiotherapy (CCRT) rapidly improved symptoms and yielded durable complete remission. Together with review of literature, our cases show that TPF chemotherapy followed by CCRT, a standard treatment for locally advanced head and neck cancer, should be more encouraged for unresectable LA-SNUC.
Publish Date 2019-03-26 03:26
Citation Watanabe S, Honma T, Murakami N, Igaki H, Mori T, Hirano H, Okita N, Shoji H, Iwasa S, Takashima A, Kato K, Kobayashi K, Matsumoto F, Yoshimoto S, Itami J, Boku N. Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by concurrent chemoradiotherapy for unresectable sinonasal undifferentiated carcinoma: two cases of report. World J Clin Cases 2019; In press
URL https://www.wjgnet.com/2307-8960/full/v7/i6/765.htm
DOI https://dx.doi.org/10.12998/wjcc.v7.i6.765
Full Article (PDF) WJCC-7-765.pdf
Full Article (Word) WJCC-7-765.docx
CARE Checklist–2016 42867-CARE-Checklist–2016-revision.pdf
Manuscript File 42867-Review.docx
Answering Reviewers 42867-Answering reviewers.pdf
Audio Core Tip 42867-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 42867-Conflict-of-interest statement.pdf
Copyright License Agreement 42867-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s) 42867-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate 42867-Language certificate.pdf
Peer-review Report 42867-Peer-review(s).pdf
Scientific Misconduct Check 42867-Scientific misconduct check.pdf
Scientific Editor Work List 42867-Scientific editor work list.pdf